MBX Biosciences, Inc. Common Stock (MBX) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
MBX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MBX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export MBX earnings history in CSV or JSON format
Free sign-in required to download data
MBX Biosciences, Inc. Common Stock (MBX) Earnings Overview
As of May 8, 2026, MBX Biosciences, Inc. Common Stock (MBX) reported trailing twelve-month net income of -$80M, reflecting -81.4% year-over-year growth. The company earned $-2.35 per diluted share over the past four quarters.
Looking at the long-term picture, MBX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$26M in fiscal 2022.
MBX Biosciences, Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CGEM (-$221M net income), KYMR (-$315M net income, -794.4% margin), PEPG (-$90M net income), MBX has comparable earnings metrics. Compare MBX vs CGEM →
MBX Earnings vs Peers
Earnings metrics vs comparable public companies
MBX Historical Earnings Data (2022–2024)
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$62M | -90.2% | -$68M | $-1.85 | - | - |
| 2023 | -$33M | -24.6% | -$35M | $-1.02 | - | - |
| 2022 | -$26M | - | -$25M | $-0.82 | - | - |
See MBX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MBX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MBX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMBX — Frequently Asked Questions
Quick answers to the most common questions about buying MBX stock.
Is MBX growing earnings?
MBX EPS fell to $-2.35, with earnings declining -81.4%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-80M.
What are MBX's profit margins?
MBX Biosciences, Inc. Common Stock net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are MBX's earnings?
MBX earnings data spans 2022-2024. The declining earnings trend is -81.4% YoY. Historical data enables comparison across business cycles.